Humacyte, Inc. Annual Nonoperating Income (Expense) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Humacyte, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2023.
  • Humacyte, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$8.97M, a 553% decline year-over-year.
  • Humacyte, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$40.4M, a 867% decline year-over-year.
  • Humacyte, Inc. annual Nonoperating Income (Expense) for 2023 was -$10.7M, a 115% decline from 2022.
  • Humacyte, Inc. annual Nonoperating Income (Expense) for 2022 was $72.6M, a 32.7% increase from 2021.
  • Humacyte, Inc. annual Nonoperating Income (Expense) for 2021 was $54.7M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$10.7M -$83.3M -115% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $72.6M +$17.9M +32.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $54.7M +$56.7M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 -$1.92M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.